DISTRIBUTORSHIP
AGREEMENT

THIS
DISTRIBUTORSHIP AGREEMENT (Agreement) is made and entered into by and between
ABBOTT LABORATORIES INC., a Delaware corporation with offices located at 100 Abbott Park
Road, Abbott Park, Illinois 60064 (Abbott) and a wholly owned subsidiary of
Abbott Laboratories, an Illinois corporation, and PSS WORLD MEDICAL, INC., a Florida
corporation with offices located at 4345 Southpoint Boulevard, Jacksonville, Florida 32216
(PSS), and effective as of September 1, 2003 (Effective Date).

RECITALS

WHEREAS,
Abbott markets a broad line of diagnostic and other health care products manufactured by
its parent company, Abbott Laboratories, throughout the world;

WHEREAS,
PSS is a physician supply company which distributes various diagnostic and other health
care products to physicians in the United States;

WHEREAS,
Abbott desires to renew the appointment of PSS as an exclusive distributor (with certain
exceptions) of certain Abbott diagnostic products in the United States under the terms and
conditions stated below; and

WHEREAS,
PSS desires to accept such appointment from Abbott under the terms and conditions stated
below;

NOW,
THEREFORE, in consideration of the premises and the mutual promises contained herein, the
parties agree as follows:

ARTICLE 1 DEFINITIONS

As
used in this Agreement, the following terms shall have the meanings set forth below:

1.1        Abbott
Trademarks/Trade Names shall mean the Abbott-owned trademarks and trade names used
by Abbott, its Affiliates (as defined in Section 1.2) and authorized distributors with
the Products (as defined in Section 1.8). A current list of such Abbott Trademarks/Trade
Names is included within Exhibit 1.1 attached hereto and incorporated herein.

1.2        Affiliate shall
mean, with respect to a party, any other business entity which directly or indirectly
controls, is controlled by, or is under common control with, such party. A business
entity or party shall be regarded as in control of another business entity if it owns, or
directly or indirectly controls, at least thirty percent (30%) of the voting stock or
other ownership interest of the other business entity, or if it directly or indirectly
possesses the power to direct or cause the direction of the management and policies of
the other business entity by any means whatsoever.

1.3        Contract
Quarter shall be consistent with calendar quarters during the Initial Term or any
Renewal Term (as defined in Section 8.1).

1.4        Contract
Year shall mean the twelve (12) month period beginning on the Effective Date and
each subsequent twelve (12) month period during the Term.

1.5        "FDA"
shall mean the United States Food and Drug Administration and any successor agency
thereto.

1.6        "Instruments"
shall mean Abbott diagnostic instruments included within the list of Products.

1.7        "Physician
Customers" shall mean all physicians in the Territory (as defined in Section 1.9)
practicing in offices located at a single geographic office site, excluding those listed
in Exhibit 1.7. The Physician Customers covered by this Agreement shall also be subject
to change by mutual agreement of the parties pursuant to Section 2.3.

1.8        Products shall
mean the Abbott diagnostic products listed in Exhibit 1.1, which may be amended from time
to time by the addition or deletion of new or existing Abbott diagnostic products to such
list, upon prices and terms to be mutually agreed upon pursuant to Sections 2.3 or
3.12(f).

1

---

1.9        Territory shall
mean the fifty (50) United States of America and the District of Columbia. Additional
terms used in specific Sections of this Agreement shall be defined in such Sections.

ARTICLE 2 APPOINTMENT AND
AUTHORIZATION

2.1        Appointment.
During the Term, Abbott hereby appoints PSS as its exclusive distributor of Products to
Physician Customers, subject to the other terms and conditions of this Agreement, and PSS
hereby accepts such appointment from Abbott, provided that Physician Customers in the
Territory may contract and have Products shipped to them directly from Abbott or through
redistribution agreements or arrangements directly with or directly by hospitals or
healthcare institutions formally affiliated with such Physician Customers (but not by
non-hospital owned distribution companies which service hospitals or healthcare
institutions and other than by such Physician Customers having admitting or staff
privileges at such hospitals or institutions). In the event any Physician Customer(s) is
purchased by or becomes affiliated with a third party, Abbott and PSS shall use
commercially reasonable best efforts to maintain PSS as the distributor of Products to
such Physician Customer. During the Term, PSS may also sell Products to the Non-Exclusive
Physicians listed on Exhibit 1.7 on a non-exclusive basis. Abbott and PSS shall take all
steps Abbott deems reasonably necessary to prevent unauthorized parties from distributing
Products to Physician Customers.

2.2        Authorization.
Abbott hereby authorizes PSS to represent itself as Abbotts exclusive authorized
distributor of Products to Physician Customers in the Territory using Abbott
Trademarks/Trade Names, provided that PSS shall not disseminate or publish any written
promotional materials or advertisements intended for customer distribution representing
itself as such without Abbotts prior written approval, which approval shall not be
unreasonably withheld. PSS shall forward any written promotional materials or
advertisements requiring Abbotts approval pursuant to the terms of this Section 2.2
to the attention of PSS National Account Manager, Dept. 939 Bldg. AP6C5 100 Abbott Park
Road Abbott Park IL 60064. Abbott shall review and comment on such written promotional
materials or advertisements within forty-five (45) days after receipt thereof from PSS.
If Abbott does not respond during such forty-five (45) day period, such promotional
materials shall be deemed approved.

2.3        Changes
to Physician Customers and Products. The Physician Customers to be supplied with Products
by PSS hereunder shall be subject to adjustment by mutual written agreement of the
parties upon review during the Annual Goal Setting Meeting (as hereinafter defined) of
the status of current Abbott direct accounts as well as to reflect changes in market
conditions, including, but not limited to, legal or regulatory changes, health care
reform, and expansion or contraction of integrated health networks. The parties
acknowledge that one purpose of such annual review of market conditions shall be to
address and correct issues which may arise if consolidation in the physician market
occurs to an extent that the total market of Physician Customers materially decreases.
During each Annual Goal Setting Meeting, the parties shall also discuss in good faith
whether to add or delete any new or existing Abbott diagnostic products to the list of
Products, with the objective of Abbott providing the longest practicable lead-time before
such diagnostic products are added to or deleted from the list of Products to facilitate
PSSs compliance with its obligations under Section 3.12. If the parties mutually
agree to any changes in the Physician Customers or Products subject to this Agreement,
the parties shall take such changes into consideration in establishing the annual goals,
compensation plans and promotional funding at the Annual Goal Setting Meeting.

2.4        Abbotts
Direct Accounts. Notwithstanding any other provision of this Agreement to the contrary,
commencing on the Effective Date, Abbott shall transfer to PSS Abbotts direct
accounts identified in Exhibit 2.4 (the Direct Accounts), provided that any
Direct Account that rejects a transfer to PSS for any reason shall remain an Abbott
account unless and until such customer subsequently agrees to transfer to PSS. Commencing
on the Effective Date and for a period of one (1) year thereafter, PSS shall be entitled
to fifty percent (50%) of the margins set forth in Exhibit 3.4(a) on all Products sold by
PSS to Direct Accounts. Commencing one (1) year after the Effective Date and continuing
through the term of this Agreement, PSS shall be entitled to one hundred percent (100%)
of the margins set forth in Exhibit 3.4(a) on all Products sold by PSS to Direct
Accounts. Upon execution of this Agreement, the parties shall work together and cooperate
with each other in good faith to develop the process, procedures and strategies pursuant
to which the Direct Accounts will be approached concerning the transfer to PSS.

2

---

ARTICLE 3 PSS OBLIGATIONS

3.1        FDA
Registration. During the Term, subject to the provisions of Section 4.5, PSS shall apply
for, shall use commercially reasonable best efforts to obtain and shall maintain any FDA
registrations or approvals and other regulatory registrations and approvals that are
required for the performance of its obligations under this Agreement, including but not
limited to an FDA Medical Device Registration Certificate if the FDA requires medical
device distributors to maintain such certificates. Upon Abbotts request, PSS shall
provide Abbott with copies of all such registrations and approvals. The parties
acknowledge their mutual belief that PSS is not required to be registered as a medical
device distributor with the FDA as of the Effective Date. If PSS should be required to be
registered as a medical device distributor because of its distribution of Products, then
PSS and Abbott shall share equally in the cost of such registration. If either Abbott or
PSS determines that such registration costs are unacceptable, such party shall give
written notice of its intent to terminate this Agreement within thirty (30) days of the
effective date of such registration requirement, such termination to take effect sixty
(60) days after the effective date of such requirement.

3.2        Promotional
Activities. During the Term, PSS shall use its commercially reasonable best efforts to
promote Products to Physician Customers in the Territory, including, but not limited to,
the following activities:

| | (a)        
      Product Promotional Materials. PSS shall make reasonably diligent use of such
          promotional materials for the Products as Abbott may furnish to PSS from time to
          time pursuant to Section 4.1. In addition, PSS may, at its own expense, develop
          and use its own promotional materials for the Products, provided such
          promotional materials are reviewed and approved in writing by Abbott prior to
          use pursuant to Section 2.2.
| | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | (b)        
         Sales Force. PSS shall retain an adequately sized, trained and motivated sales
          force to promote the Products to Physician Customers in the Territory.
| | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | (c)        
Compensation of Sales Force. PSS shall maintain a separate sales force commission/compensation program for the immunoassay Products in accordance with
 Section 3.3(a), and any changes to such program shall be reviewed by the
parties at the applicable Annual Goal Setting Meeting (as hereinafter defined).
PSS and Abbott shall use their commercially reasonable best efforts promptly to
develop a marketing program(s) that emphasizes retention and growth in high
volume immunoassay Physician Customer accounts.
| | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | (d)        
           Sales Calls. PSS sales representatives shall make adequate sales calls to
          Physician Customers to promote actively the Products in a manner consistent with
          PSSs current call frequency with the objective of maintaining a high level
          of Physician Customer satisfaction.
| | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | (e)        Trade
Shows. Upon Abbotts request, PSS shall provide personnel to assist           Abbott
in Abbotts participation in conferences, conventions, exhibits and           trade
shows promoting the Products to Physician Customers in the Territory in           such
manner as may be mutually agreed upon. Abbott shall provide PSS with
          appropriate prior written notice of such conferences, conventions, exhibits and
          trade shows.
| | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | (f)        
Degree of Efforts. PSS shall use a degree of effort in promoting the Products           to
Physician Customers in the Territory that is at least as high as the degree           of
effort PSS uses to promote its most important products to Physician Customers
          in the Territory, including but not limited to designating Abbott as a
preferred           supplier of selected products in PSSs CAN DO and
SRX Sales           Promotion Programs or any equivalent supplier emphasis programs and
placing a           high degree of PSS leadership emphasis on the sale of Products,
subject to the           terms and conditions of such programs.
| | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | (g)        
Placement of Instruments. PSS shall use its commercially reasonable best           efforts to place
Instruments with Physician Customers by (i) sale, (ii)           lease/rental, or (iii)
participation in the Abbott Diagnostics Purchase Plan           (APP Program),
whereby Physician Customers shall be allowed the use           of an Abbott Instrument in
consideration for purchasing from PSS certain minimum           quantities of Reagent
Products, as the case may be. PSS shall be responsible for           making any necessary
contractual arrangements with Physician Customers for the           sale or lease/rental
of Instruments, and Physician Customers who elect to           receive an Abbott
Instrument by participation in the APP Program shall enter           into a written
agreement with Abbott in the form of Exhibit 3.2 attached hereto           and
incorporated herein or in any other form approved in advance and in writing           by
Abbott, under the APP Program participation criteria and conditions set forth
          in Exhibit 3.2.
| | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

3

---

| | (h)        
Abbott Presence at Sales Meetings. PSS shall allow Abbott representatives to           attend
all PSS national sales/marketing meetings. PSSs charge to Abbott to
          attend national sales/marketing meetings has been included in Abbotts
          promotional/sales support payment set forth in Section 4.4. PSS shall allow
          Abbott representatives to attend all PSS regional and branch sales/marketing
          meetings. The charge for Abbott sales representatives to attend PSS regional
and           branch sales/marketing meetings is included in the Activity-Specific
Funding           payments made in accordance with Section 4.4. PSS shall provide Abbott
with           appropriate prior written notice of all such national, regional and
district           branch meetings.
| | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

3.3        Sale
and Distribution of Products. During the Term, Abbott shall sell to PSS and PSS shall
purchase from Abbott PSSs total requirements of Products for distribution to
Physician Customers, subject to the following conditions:

| | (a)        
     Annual Goal Setting. Abbott and PSS shall meet no later than February 15 of
          each calendar year during the Initial Term and any Renewal Term to establish
          annual goals, review compensation plans for each party, mutually agree on rules
          for use of promotional funding as set in Section 4.4, set dates for Quarterly
          Reviews and discuss any Physician Customer and/or Product changes (the
          Annual Goal Setting Meeting). Each party shall be responsible for
          insuring the attendance at each Annual Goal Setting Meeting of its personnel
          necessary to fulfill the objectives of the Annual Goal Setting Meeting,
          including, for example, its operations, finance, e-commerce and training
          personnel. PSS shall review its sales force commission/compensation program,
          particularly as it relates to the sale of Products, during the Annual Goal
          Setting Meeting. The strategic intent of the PSS sales force compensation
          program for Products, as set forth in this Section, is to achieve the objectives
          of this Agreement. Moreover, sales of Instruments shall be a condition to PSS
          sales representatives participating in PSSs CAN DO sales force
          commission/compensation equipment program.
| | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | PSS shall
not impose new customer fees or increase existing fees that disproportionately burden
Product sales without the prior written approval of Abbott. PSS shall not alter its
commission structure or otherwise revise any of its policies, procedures or processes in
any manner that disadvantages Products. The following issues shall also be discussed at
the Annual Goal Setting Meeting (i) perceived gaps in product availability, including
plans to pursue alternative vendors and new and/or alternative Abbott products, (ii)
internal accounting and/or financial policy changes that may materially affect the other
party, (iii) appropriate responses to declining or obsolete Products, and (iv) any other
topic a party deems relevant.
| | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | Prior to
each April 1 following an Annual Goal Setting Meeting during the Term, Abbott and PSS
shall enter into a letter agreement setting forth sales goals, amounts and forms of
marketing/promotional funds to be paid by Abbott, including conditions thereto, and
minimum numbers of Abbott sales support representatives and PSS sales representatives. In
the event that PSS and Abbott are unable to agree upon sales goals for any Contract Year
within thirty (30) days of the applicable Annual Goal Setting Meeting, the sales goals
for such Contract Year shall be set at five percent (5%) in excess of the actual sales
for the prior Contract Year, on a category-by-category basis.
| | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | (b)        

           Biannual Reviews. PSS shall review the status of its activities under this
          Agreement with Abbott twice per Contract Year at mutually agreed upon times and
          locations (the Biannual Review). At each Biannual Review, the
          parties shall review PSSs performance under this Agreement and factors
          contributing to PSSs progress on the goals set at the Annual Goal Setting
          Meeting (the Annual Goals), including but not limited to delays in
          Product launches, major competitive changes and market conditions. At each
          Biannual Review, the parties shall also review Abbotts field sales
          performance, customer service performance and overall Product quality. The
          Biannual Review shall also serve as the forum for the parties to present and
          propose alternative strategies necessary to achieve the Annual Goals and for the
          Parties to discuss future product development needs and opportunities.
| | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | (c)        
       Product Adjustments. [****************************************]
| | ----------------------------------------------------------------------------------

| | (d)               Purchase
of Products for Resale. [********************************]
| | -------------------------------------------------------------------------------------

4

---

3.4        Purchase
Prices.  [***************************************************]

| | (a)        Price
Adjustments.  [*******************************************]
| | ----------------------------------------------------------------------------

| | (b)        Resale
Prices.  [***********************************************]
| | ----------------------------------------------------------------------------

3.5        Other
Terms and Conditions of Sale.  PSS's purchase of Products from Abbott hereunder shall
also be subject to the         following terms and conditions of sale:

| | (a)        Payment
Terms. Payment terms for all shipments of Products to PSS shall be net           thirty
(30) days from the date of Abbotts invoice to PSS for each shipment           of
Products, provided that Abbott shall not invoice PSS until the date of actual
          Product shipment.
| | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | (b)        Order
Entry. PSS shall use its normal purchase order forms to order Products           from
Abbott hereunder, provided that such purchase orders may specify only the
          description and quantities of Products ordered (including identification of
          Products by the appropriate Abbott product list numbers), the requested
shipment           date, and the shipment destination. Any other terms and conditions
stated on           such purchase orders shall not be applicable to purchases hereunder.
| | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | (c)        
           Delivery. Abbott shall use its commercially reasonable best efforts to ship
          Products to PSS, F.O.B. Abbotts manufacturing facilities in accordance
          with PSSs requested delivery dates, except as otherwise provided in
          Exhibit 3.5(c) attached hereto and incorporated herein. Such shipments shall be
          sufficient in amount and sufficiently timely to permit PSS to meet its customer
          order fill rate standards set forth in Section 3.6 hereof. Except as otherwise
          mutually agreed, Abbott shall ship Instruments directly to Physician Customers.
          Abbott shall select the carriers for all shipments of Products hereunder,
          provided that (i) Abbott shall use its commercially reasonable best efforts to
          select carriers offering competitive prices with reasonably satisfactory quality
          and reliability standards and (ii) PSS may suggest alternate carriers for
          Abbotts consideration if PSS believes cost savings can be achieved with
          alternate carriers having comparable quality and reliability to Abbotts
          designated carrier(s). Except as provided in Exhibit 3.5(c), PSS shall be
          responsible for shipping charges for the Products (including any Products
          shipped directly to Physician Customers), which shall be added to Abbotts
          invoices to PSS, provided that PSS shall be entitled to shipping charge
          discounts in accordance with Exhibit 3.5(c). Title and risk of loss shall pass
          to PSS upon delivery of the Products to the carrier for shipment.
| | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | (d)
       
           Returns. Except for return of any defective Products which do not comply with
          the applicable warranty for repair or replacement by Abbott and other returns
          authorized in accordance with the Returned Goods Policy set forth in Exhibit
          3.5(d) attached hereto and incorporated herein, all sales of the Products are
          final and no Products may be returned without Abbotts prior written
          consent. Upon PSSs request, and with Abbotts approval, which
          approval shall not be unreasonably withheld, Abbott shall refurbish Instruments
          that are returned hereunder for resale by PSS to Physician Customers in such a
          manner as may be mutually agreed upon in accordance with applicable laws and
          regulations. Except as otherwise mutually agreed, the cost of such refurbishment
          shall be Abbotts standard refurbishment cost and such cost shall be borne
          by PSS.
| | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | (e)        Warranty.
Abbott warrants that (i) Instruments (excluding refurbished           Instruments) shall
comply with Abbotts standard warranty therefor set           forth in the
applicable Operators Manual, (ii) refurbished Instruments           shall comply
with Abbotts standard warranty therefor for a period of six           (6) months
from the date of shipment by Abbott, and (iii) Products other than           Instruments
shall comply with Abbotts standard warranty therefor set forth           in the
then current Abbott Diagnostics Division Price Catalog. ABBOTT MAKES NO           OTHER
WARRANTIES, WHETHER EXPRESS OR IMPLIED, AND ABBOTT EXCLUDES AND DISCLAIMS           ANY
OTHER WARRANTIES INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF
          MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. EXCEPT AS PROVIDED IN
          SECTION 7.3, ABBOTT SHALL HAVE NO LIABILITY FOR INDIRECT, INCIDENTAL, SPECIAL
OR           CONSEQUENTIAL DAMAGES RELATING TO THE SALE OR USE OF THE PRODUCTS, AND
          ABBOTTS LIABILITY THEREFOR SHALL BE LIMITED TO THE COST OF REPAIR OR
          REPLACEMENT OF DEFECTIVE PRODUCTS.
| | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

5

---

3.6        Inventory.
PSS shall use commercially reasonable best efforts to maintain a level of inventory of
all Products that PSS distributes in the Territory (excluding Instruments) sufficient to
ensure that PSS is able to fill at least ninety-five percent (95%) of Physician Customers orders
within one (1) business day of PSSs receipt of such orders. At PSSs request,
Abbott operations personnel shall discuss with PSS Product distribution related to
Product flow. PSS shall store Product inventory in its distribution centers in a manner
appropriate for maintaining such Products in good and saleable condition as required on
Product labeling and consistent with the Product dating and storage conditions specified
by Abbott. All PSS distribution centers shall conform to the temperature control
requirements set forth on Product labeling, and shall be subject to periodic audit by
Abbott by no more than three (3) Abbott representatives per audit at mutually agreeable
reasonable times and upon reasonable prior notice. PSSs current list of
distribution centers is set forth in Exhibit 3.6, attached hereto and incorporated
herein, and PSS shall promptly notify Abbott in writing of any changes to this list at
least once per Contract Quarter. PSS shall maintain a distribution record system
reasonably sufficient to enable Abbott and/or PSS to promptly notify Physician Customers
of Product safety information or issues. If required by applicable laws or regulations,
PSS shall establish and maintain an auditable distribution record system including an
accurate, traceable lot number control system which is traceable to Physician Customers
for such Products purchased from PSS. In the event that compliance with applicable laws
and regulations requires PSS to make significant modification to the record system in
place on the Effective Date, then PSS and Abbott shall share equally in the documented
cost of such modifications. If either Abbott or PSS determines that such modification
costs are unacceptable, such party shall give written notice to the other party of its
intent to terminate this Agreement within thirty (30) days of such determination, such
termination to take effect sixty (60) days after such notice.

3.7        Records.
PSS shall maintain complete and accurate records of Products delivered hereunder,
inventory and sales to Physician Customers. PSS shall make such records available to
Abbott within fifteen (15) days after the end of each calendar month in an automated
format to be mutually agreed upon and Abbott may utilize such records in its Quality
Field Watch Program in the Abbott Customer Support Center.

3.8        Reports
and Customer Lists.  [***************************************]

3.9        Product
Recalls and Complaints. Upon Abbotts request to the PSS Regulatory Affairs and
Marketing Departments, PSS shall assist Abbott in identifying Physician Customers for
notification in connection with any Product recalls. Within twenty-four (24) hours of PSSs
own receipt of notice (at PSS headquarters) of any Physician Customer technical
questions, complaints or actual or alleged Product defects, PSS shall notify Abbott
thereof orally, followed promptly by a written notice using the Abbott Laboratories
Product Complaint Inquiry Form, the current form of which is set forth in Exhibit
3.9, attached hereto and incorporated herein.

3.10        Billing
and Collections. PSS shall have sole responsibility for billings to and collections from
Physician Customers for PSSs sales of Products to Physician Customers.

3.11        Use
of Abbott Trademarks/Trade Names. PSS shall promote the Products to Physician Customers
in the Territory using Abbott Trademarks/Trade Names and PSS shall not use any name, mark
or style to identify the Products other than Abbott Trademarks/Trade Names without Abbotts
prior written consent. PSS acknowledges that Abbott Trademarks/Trade Names are valid
trademarks and trade names and the sole property of Abbott, and PSS shall not disparage
or challenge the validity of Abbott Trademarks/Trade Names during the Term. PSS shall
promptly notify Abbott of any actual or alleged infringements of Abbott Trademarks/Trade
Names of which PSS becomes aware during the Term. Nothing contained herein shall be
construed to authorize PSS: (a) to use any Abbott Trademarks/Trade Names as a style or
name, or as a part of the style or name, of any firm, partnership or corporation; (b) to
apply Abbott Trademarks/Trade Names to any goods other than the Products; or (c) at any
time after the termination of this Agreement, to apply Abbott Trademarks/Trade Names to
goods or to any other use whatsoever.

3.12        
Non-Competition Obligations.  [*************************************]

| | (a)        Competitive
Products.  [***************************************]
| | ---------------------------------------------------------------------------

| | (b)        Excluded
Competitive Products.  [*****************************]
| | --------------------------------------------------------------------------

| | (c)        Exception
for Recall or Withdrawal.  [*****************************]
| | -------------------------------------------------------------------------------

| | (d)        Compliance
Audit.  [*****************************************]
| | -------------------------------------------------------------------------

6

---

ARTICLE 4 ABBOTT OBLIGATIONS

4.1        Promotional
Materials. At no cost to PSS, Abbott shall provide PSS with such promotional materials
relating to the Products as Abbott deems appropriate in such quantities as may be
mutually agreed for PSSs use hereunder.

4.2        Training.
At no cost to PSS, during the Initial Term and any Renewal Term Abbott shall provide PSS
and Physician Customers with appropriate training in the use and operation of Products.

4.3        Service.
Unless otherwise mutually agreed in writing, Abbott or its designees shall use its
commercially reasonable best efforts to perform all warranty service on Products and
maintenance service for Instruments within seventy-two (72) hours of proper notification
to Abbott of such service request. Unless otherwise mutually agreed by the parties in
writing, PSS shall not perform any such warranty or maintenance services for any Products
(including Instruments) and PSS shall refer all Physician Customer service inquiries to
Abbott.

4.4        Advertising/Promotional
Support. During each Contract Year, Abbott shall pay PSS an advertising/promotional
support payment to be used by PSS to support its national sales meeting and promotional
programs relating to the Products, including but not limited to CAN DO and
Product promotional programs (including regional, local, university and other programs).
Except as provided below, the amount of the advertising/promotional support payment shall
be Eight Hundred Thousand Dollars ($800,000) per Contract Year, such payment to be made
prior to the beginning of such Contract Year. The parties acknowledge that the
advertising/promotional support payment for the first Contract Year has been partially
paid prior to the Effective Date and that the remaining portion of such payment, in the
amount of Two Hundred Sixty-Six Thousand Six Hundred Sixty-Seven Dollars ($266,667),
shall be paid within ten (10) business days of the Effective Date.

In
addition to the advertising/promotional support payment referenced above, Abbott shall
provide funding to PSS to support expenses incurred by PSS in connection with specified
PSS promotional activities (Activity-Specific Funding), including, but not
limited to, local PSS branch meetings, appropriate local PSS branch sales incentives,
local PSS product fairs and regional PSS meetings. The parties acknowledge that the
Activity-Specific Funding for the first Contract Year is One Hundred Eighty-Six Thousand
Dollars ($186,000) and that such payment shall be paid within ten (10) business days of
the Effective Date. The parties shall mutually agree on the amount of the
Activity-Specific Funding for subsequent Contract Years. Abbott shall pay the
Activity-Specific Funding to PSS within ten (10) business days of the partiesagreement
on the amount of the funding for any Contract Year. Upon receipt, PSS shall hold the
Activity-Specific Funding and shall release Activity-Specific Funding amounts only at the
request of an Abbott District Manager to fund PSS branch expenses approved by Abbott.

4.5        Assistance
with PSS Legal Compliance. If the FDA or any other regulatory agency institutes any new
registration or approval requirements during the Initial Term or any Renewal Term and PSS
is not able to comply immediately with such requirements, then for a period of up to
three (3) months from the effective date of such requirements Abbott shall, upon PSSs
request and if Abbott itself is able to comply with such requirements, supply Physician
Customers with Products directly until such time as PSS complies with such requirements.
PSS shall receive contract credit for all such sales and all shipping charges for such
direct shipments shall be paid by PSS or the Physician Customers receiving such
shipments.

4.6        Field
Sales Force.  Abbott will maintain a field sales force adequate to support PSS in the
attainment of its sales quotas.

4.7        Voluntary
Product Withdrawals and Discontinuations. To the extent practicable, Abbott will provide
PSS advance written notice of any voluntary Product withdrawal or significant Product
change. Abbott will provide PSS with written notice as soon as practicable of any Product
discontinuation.

7

---

ARTICLE 5 CONFIDENTIALITY AND
PUBLICITY

5.1        Confidentiality.
During the Initial Term and any Renewal Term and for a period of ten (10) years
thereafter, each party shall keep in confidence any information and/or documentation
received from the other (Confidential Information), and each party shall use
the Confidential Information only for purposes of this Agreement. Except as expressly
provided in this Agreement, neither party shall at any time use or permit others to use
any Confidential Information for any purposes. The foregoing obligations shall not apply
to, and the definition of Confidential Information does not include:

| | (a)        
Publicly Available Information  information that was already in the public domain
or subsequent to disclosure to a party becomes part of the public domain other
than through the fault of such party;
| | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | (b)        
Previously Known Information  information that was rightfully known (as
          evidenced by written records) prior to the date of disclosure by the other
          party;
| | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | (c)        
Subsequently Disclosed Information  information that was received from a third party
having a lawful right to disclose the same; or
| | ------------------------------------------------------------------------------------------------------------------------------------------------

| | (d)          Legally
Required Disclosures of Information  information that, in the opinion of
a partys counsel, is required to be disclosed to comply with  any
applicable law, regulation or order of a government authority or court of
          competent jurisdiction, in which event the party required to make such
          disclosure shall advise the other party in advance of the need for such
          disclosure and use its best efforts to obtain confidential treatment of such
          information.
| | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | Notwithstanding the foregoing, any party may disclose Confidential Information to its employees and agents to
the extent reasonably necessary for the performance of this Agreement, provided that such
recipients are subject in writing to obligations of confidentiality and non-use with
respect to such information to the same extent as each party is obligated hereunder.
| | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

5.2        Publicity.
Neither party may disclose the existence or terms of this Agreement, or make any public
relations announcement concerning this Agreement or the Abbott-PSS business relationship,
without the prior written consent of the other party, except as may be legally required
in the determination of the disclosing partys legal counsel. If either party
desires to or believes it is legally required to announce the execution of this
Agreement, the parties shall cooperate in determining the date and format of such
announcement, giving consideration to the requirements of any applicable laws and
regulations. Abbott acknowledges that PSS may discuss this Agreement generally with
securities analysts and that this Agreement will be disclosed and generally described in
PSS securities law filings, provided that PSS shall give Abbott reasonable advance notice
of any such public disclosure, to the extent reasonably practicable and legally
permissible. Abbott also acknowledges that this Agreement must be filed by PSS with the
Securities and Exchange Commission (the SEC) as a material contract. PSS
agrees to seek confidential treatment of certain pricing information
contained in this Agreement in any such SEC filing.

ARTICLE 6 CERTAIN REPRESENTATIONS
AND WARRANTIES

Each party hereby represents and
warrants to the other party as follows:

6.1        Corporate
Existence and Power. Such party (a) is a corporation duly organized, validly existing and
in good standing under the laws of the state in which it is incorporated, (b) has the
corporate power and authority and the legal right to own and operate its property and
assets, to lease the property and assets it operates under lease, and to carry on its
business as it is now being conducted and as it is proposed to be conducted hereunder,
and (c) is in compliance with all requirements of applicable laws and regulations, except
as previously disclosed to the other party or to the extent that any noncompliance would
not have a material adverse effect on the properties, business, or financial condition of
such party and would not materially and adversely affect such partys ability to
perform its obligations under this Agreement.

8

---

6.2        Authorization
and Enforcement of Obligations. Such party (a) has the corporate power and authority and
the legal right to enter into this Agreement and to perform its obligations hereunder,
and (b) has taken all necessary corporate action on its part to authorize the execution
and delivery of this Agreement and the performance of its obligations hereunder. This
Agreement has been duly executed and delivered on behalf of such party, and constitutes a
legal, valid, binding obligation, enforceable against such party in accordance with its
terms.

6.3        Consents.
All necessary consents, approvals and authorizations of all governmental authorities and
other persons required to be obtained by such party in connection with the execution,
delivery and performance of this Agreement have been obtained.

6.4        No
Conflict. The execution and delivery of this Agreement and the performance of such partys
obligations hereunder (a) do not conflict with or violate any requirement of applicable
laws or regulations and (b) do not conflict with, violate or breach or constitute a
default or require any consent under, any contractual obligation of such party.

6.5        Compliance
With Laws. Such party shall perform its obligations hereunder in compliance with all
applicable federal, state and local laws, regulations and accepted industry guidelines.

ARTICLE 7 INDEMNIFICATION AND
INSURANCE

7.1        PSS
Indemnification. PSS shall defend, indemnify and hold harmless Abbott, its Affiliates,
and the officers, directors, employees and agents of Abbott and its Affiliates, from and
against any and all liabilities, damages, claims, demands, costs, or expenses (including
reasonable attorneys fees) claimed by any third party for any property or other
economic loss or damage or injury or death suffered by it to the extent the same is
determined to have been caused by PSSs negligence, willful misconduct or breach of
this Agreement.

7.2        PSS
Insurance. During the Term, PSS and Abbott shall maintain general business liability
insurance coverage, including, if applicable, self-insurance, in the minimum aggregate
amount of Five Million Dollars ($5,000,000).

7.3        Abbott
Indemnification. Abbott shall defend, indemnify and hold harmless PSS, its Affiliates,
and the officers, directors, employees and agents of PSS and its Affiliates, from and
against any and all liabilities, damages, claims, demands, costs, or expenses (including
reasonable attorneys fees) claimed by any third party for any property or other
economic loss or damage or injury or death suffered by it to the extent the same is
determined to have arisen out of or been attributable to: (i) any defect in the design or
manufacture of the Products; (ii) any violation of any proprietary right of such third
party relating to the use of a Product in accordance with the procedures and for the uses
set forth in the operators manual, product insert or other instructions setting
forth the intended use for the applicable Product; or (iii) Abbotts negligence,
willful misconduct or breach of this Agreement. Abbotts obligations hereunder will
apply only when the applicable Product is lawfully used, lawfully dispensed or lawfully
distributed and used in accordance with the applicable operators manual, product
insert or as otherwise instructed in writing by Abbott. Any other use of the applicable
Product will not be subject to this indemnity.

7.4        Conditions
of Indemnifications. If Abbott seeks indemnification from PSS pursuant to Section 7.1 or
PSS seeks indemnification from Abbott pursuant to Section 7.3, the party seeking
indemnification shall (a) notify the other party in writing of the claim or suit for
which indemnification is sought within fifteen (15) days after the date the party seeking
indemnification itself receives notice of such claim or suit and (b) allow the other
party to control the defense or settlement of such claim or suit, provided that the party
seeking indemnification may, at its own option and expense, participate in the defense or
settlement of such claim or suit, and provided further that the indemnifying party shall
not enter into any binding settlement, consent to any judgment or otherwise resolve any
such claim or suit pursuant to which the other party would be obligated to take or
refrain from taking any action or to make any payments or admissions, without the other
partys prior written consent.

9

---

ARTICLE 8 TERM AND TERMINATION

8.1        Expiration.
Unless terminated earlier by written agreement of the parties or pursuant to Sections
3.1, 3.6, 3.12(c), 3.12(d), 8.2, 8.3 or 8.4, the term of this Agreement shall commence on
the Effective Date and continue until three (3) years thereafter (Initial Term).
Upon expiration of the Initial Term, the Agreement shall continue automatically for
additional successive one (1) year periods (each one (1) year period a Renewal Term)
unless terminated by either party by giving written notice to the other party not less
six (6) months prior to expiration of the Initial Term or any Renewal Term.

8.2        Early
Termination by Either Party. Either party shall have the right, without prejudice to any
other rights or remedies available to it, to terminate this Agreement for cause by
written notice to the other party in any of the following events:

| | (a)        Bankruptcy.
A party may terminate this Agreement if the other party becomes           insolvent, is
adjudged bankrupt, applies for judicial or extra-judicial           settlement with its
creditors, makes an assignment for the benefit of its           creditors, voluntarily
files for bankruptcy or has a receiver or trustee (or the           like) in bankruptcy
appointed by reason of its insolvency, or in the event an           involuntary
bankruptcy action is filed against the other party and not dismissed           within
sixty (60) days, or if the other party becomes the subject of liquidation           or
dissolution proceedings or otherwise discontinues business.
| | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | (b)         Default.
A party may terminate this Agreement if the other party commits a           material
breach of this Agreement and the party alleged to be in breach fails to           (i)
cure such breach or (ii) commence dispute resolution proceedings under           Section
9.11 contesting whether a breach has occurred and/or whether such breach           is a
material breach within sixty (60) days after receipt of written notice from           the
party asserting the breach. For purposes of this Section, a material breach           by
PSS shall include, but is not limited to, any material breach by PSS of its
          non-competition obligations pursuant to Section 3.12.
| | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

8.3        Termination
for Business Combination. Each party shall have the right, without prejudice to any other
rights or remedies available to it, to terminate this Agreement for cause by written
notice to the other party, to be given as soon as ten (10) days after such party has
received written notice from such other party that a Business Combination has occurred.
For purposes of this Section 8.3, a Business Combination shall mean a
transaction in which a controlling interest in a party is acquired in a merger, share
exchange, sale of assets or otherwise by any third party.

8.4        Other
Termination by Abbott. In addition to Abbotts termination rights pursuant to
Sections 3.1, 3.6, 3.12(c), 3.12(d), 8.1, 8.2 and 8.3, Abbott shall have the right,
without prejudice to any other rights or remedies available to it, to terminate this
Agreement for cause by giving PSS ninety (90) days prior written notice in the
event that Products are no longer serviced and delivered from dedicated PSS warehouses
which maintain same day and/or next day service and delivery.

8.5        PSS
Obligations Upon Termination.  [***********************************]

8.6        Effect
of Termination. Termination or expiration of this Agreement through any means and for any
reason shall not relieve the parties of any obligations accruing prior thereto, and shall
be without prejudice to the rights and remedies of either party with respect to any
breach of any of the provisions of this Agreement.

ARTICLE 9 MISCELLANEOUS

9.1        Entire
Agreement; Amendment. This Agreement contains the entire understanding of the parties
with respect to the subject matter thereof and supersedes all previous verbal and written
agreements, representations and warranties with respect to such subject matter, including
the Distributorship Agreements between the parties dated as of April 1, 1995 and December
1, 2000, provided that the confidentiality provisions of such Distributorship Agreements
shall continue to survive for ten (10) years after the term of such agreements, as
contemplated in Sections 6.1 and 5.1 thereof, respectively. This Agreement may be amended
only by a written agreement signed by authorized representatives of both parties.

10

---

9.2        Force
Majeure. Failure of either party to perform its obligations under this Agreement (except
the obligation to make payments) shall not subject such party to any liability or
constitute a breach of this Agreement if such failure is caused by any event or
circumstances beyond the reasonable control of such nonperforming party, including
without limitation acts of God, fire, explosion, flood, drought, war, riot, sabotage,
embargo, strikes or other labor trouble, failure in whole or in part of suppliers to
deliver on schedule materials, equipment or machinery, interruption of or delay in
transportation (unless caused by the party so affected), a national health emergency or
compliance with any order or regulation of any government entity. A party whose
performance is affected by a force majeure event shall take prompt action to remedy the
effects of the force majeure event.

9.3        Waiver.
A failure by either party to enforce any rights under this Agreement shall not be
construed as a waiver of such rights nor shall a waiver by either party in one or more
instances by construed as constituting a continuing waiver or as a waiver in other
instances. Any waiver of breach executed by either party shall affect only the specific
breach and shall not operate as a waiver of any subsequent or preceding breach.

9.4        No
Assignment. Except as otherwise expressly provided herein, neither party may sell,
assign, pledge, subcontract or otherwise dispose of all or any portion of its rights or
obligations under this Agreement except, in the case of Abbott, to an Affiliate;
provided, however, that Abbott may assign all of its rights and obligations under this
Agreement to the extent relating to the Rapid Diagnostic Products to any successor to all
or substantially all of Abbotts Rapid Diagnostic Products business. Subject to the
foregoing, this Agreement shall inure to the benefit of and be binding upon the parties
and their respective permitted successors and assigns.

9.5        Severability.
If any clause or provision of this Agreement is declared invalid or unenforceable by a
court of competent jurisdiction, such provision shall be severed and the remaining
provisions of the Agreement shall continue in full force and effect. The parties shall
use all commercially reasonable best efforts to agree upon a valid and enforceable
provision as a substitute for the severed provision, taking into account the intent of
this Agreement.

9.6        Relationship
of Parties. The parties shall have the status of independent contractors under this
Agreement and nothing in this Agreement shall be construed as authorization for either of
the parties to act as a joint venturer with, agent for, or partner of, the other party.

9.7        Non-Solicitation.
During the Initial Term and any Renewal Term and for a period of six (6) months
thereafter, neither party nor their Affiliates shall solicit for employment or employ any
employee of the other party without the other partys prior written consent.

9.8        Notices.
Any notice, request or other communication required to be given pursuant to the
provisions of this Agreement shall be in writing and shall be deemed to be given when
delivered in person or five (5) days after being deposited in the United States mail,
postage prepaid, certified, return receipt requested, or by overnight courier (return
receipt requested), to the parties addressed as follows:

11

---

| | (a)                            If
to Abbott to:
| | -----------------------------------------------

| |                                                                                                                                                                                                                                                                                                                                                                                                                 
| | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| | PSS National Account Manager 
Abbott Diagnostics Division  
Abbott Laboratories 
100 Abbott Park Road 
D-02FC, AP6C
Abbott Park, Illinois  60064-3500
Tel: (847) 935-5775
Fax: (847) 935-0633
With a copy to: 
Abbott Laboratories
Domestic Legal Operations 
100 Abbott Park Road D-322, AP6D
Abbott Park,  Illinois 60064-6049 
Attention: Divisional Vice President 
Tel: (847) 937-5032  Fax: (847) 938-1206

| | (b)               If to PSS to:
| | -------------------------------

| |                                                                                                                                                                                                                                                                                               
| | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| | Executive Vice President
PSS World Medical, Inc.
4345 Southpoint Boulevard 
Jacksonville, Florida 32216
Tel: (904) 281-0011 Fax: (904) 281-9555 

With a copy to:
Chanley T. Howell, Esq.
Foley & Lardner
200 Laura Street
Jacksonville, Florida 32202
Tel: (904) 359-8745 Fax: (904) 359-8700

Either party may change its address
or its fax number by giving the other party written notice, delivered in accordance with
this Section 9.8.

9.9        Further
Instruments. Each party shall execute and deliver such further instruments and do such
further reasonable acts and things as reasonably may be required to carry out the intent
and purpose of this Agreement.

9.10        Governing
Law. The validity, performance, construction, and effect of this Agreement shall be
governed by the laws of the State of Illinois, without giving effect to conflict of law
rules.

9.11        Alternative
Dispute Resolution. All disputes arising out of or in connection with this Agreement
(except those involving actions commenced by or involving third parties) shall be
resolved by Alternative Dispute Resolution (ADR) proceedings in accordance
with Exhibit 9.11, attached hereto and incorporated herein.

9.12        Counterparts.
This Agreement may be executed in any number of counterparts, each of which shall be an
original as against the party whose signature appears thereon, but all of which taken
together shall constitute one and the same instrument, and signatures received by
facsimile transmission shall constitute legal and valid signatures hereto.

12

---

IN WITNESS
WHEREOF, each party has caused this Agreement to be signed by its duly authorized
representative as of the Effective Date.

|ABBOTT LABORATORIES INC.                                                                         |  | PSS WORLD MEDICAL, INC.                                                                                          
|------------------------------------------------------------------------------------------------ |  | -----------------------------------------------------------------------------------------------------------------
|By: __________________________  
                                
Title: _______________________ |  | By: /s/ John F. Sasen
      John F. Sasen
      Title: Executive Vice President and
      Chief Marketing Officer

13

---

EXHIBIT 1.1

PRODUCTS

- Rapid Diagnostic products including
Test kitsControls
- Test kits
- Controls
- Diagnostic EIA Products
Quantum(TM) analyzerReagentsCalibratorsControlsInstrument accessories
- Quantum(TM) analyzer
- Reagents
- Calibrators
- Controls
- Instrument accessories
- Cell-Dyn(R)System including
Cell-Dyn Analyzers: 1700/CD 1700CS/CD 3000CS/CD 3000SL/CD 3200CS/ CD 3200SL/CD 3500CS/CD 3500SL/CD3700CS/CD 3700SL/CD4000SL/CD1800ReagentsCalibratorsControlsInstrument accessoriesReagent accessoriesInstrument disposables
- Cell-Dyn Analyzers: 1700/CD 1700CS/
- CD 3000CS/CD 3000SL/CD 3200CS/ CD 3200SL/CD 3500CS/CD 3500SL/CD3700CS/CD 3700SL/CD4000SL/CD1800
- Reagents
- Calibrators
- Controls
- Instrument accessories
- Reagent accessories
- Instrument disposables
- IMx(R)System including
IMx analyzerReagentsCalibratorsControlsInstrument accessoriesReagent accessoriesInstrument disposables
- IMx analyzer
- Reagents
- Calibrators
- Controls
- Instrument accessories
- Reagent accessories
- Instrument disposables
- AxSYM(R)System including
AxSYM analyzerReagentsCalibratorsControlsInstrument accessoriesReagent accessoriesInstrument disposables
- AxSYM analyzer
- Reagents
- Calibrators
- Controls
- Instrument accessories
- Reagent accessories
- Instrument disposables
- Aeroset(R)System including
Aeroset analyzerReagentsCalibratorsControlsInstrument accessoriesReagent accessoriesInstrument disposables
- Aeroset analyzer
- Reagents
- Calibrators
- Controls
- Instrument accessories
- Reagent accessories
- Instrument disposables
- c-8000 System including
c-8000 AnalyzerReagentsCalibratorsControlsInstrument accessoriesReagent accessoriesInstrument disposables
- c-8000 Analyzer
- Reagents
- Calibrators
- Controls
- Instrument accessories
- Reagent accessories
- Instrument disposables
- Abbott Spectrum(R)System including
Spectrum AnalyzerReagentsCalibratorsControlsInstrument accessoriesReagent accessoriesInstrument disposables
- Spectrum Analyzer
- Reagents
- Calibrators
- Controls
- Instrument accessories
- Reagent accessories
- Instrument disposables

The ILC, currently in development by
Abbott as a new Immunoassay analyzer, shall be a Product upon release.

---

GUIDE TO SPELLING OF
U.S. TRADEMARKS

|ADD                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|A-CHAT(TM)                                         
A-GENT(R)                                          
AARTS (with design)(R)                             
                                                   
ABBOTT ADVANTAGE(TM)                               
                                                   
ABBOTT ALCYON(R)                                   
                                                   
ABBOTT ALLIANCE(R)                                 
                                                   
ABBOTT BBS(TM)                                     
                                                   
ABBOTT DMS(TM)                                     
                                                   
ABBOTT EXTEND(TM)                                  
                                                   
ABBOTT MATRIX(R)                                   
                                                   
ABBOTT PRISM(R)
ABBOTT SPECTRUM(R)                                 
ABBOTT SPECTRUM EPX(R)                             
ABBOTT SYNETIICS(TM)                               
ABBOTT TESTPACK(R)                                 
 ABBOTT VP(TM)                                     
ABBOTTBASE(R)                                      
                                                   
ABT(R)                                             
                                                   
ADX(R)                                             
                                                   
ADX (stylized)(R)                                  
                                                   
AEROSET(R)                                         
                                                   
AIS(TM)                                            
                                                   
ALCYON(R)                                          
                                                   
AMPLIONC(R)                                        
ARCHITECT(R)                                       
ARCHITECT ARM(TM)                                  
ASIST(TM)                                          
AUSAB(R)                                           
AUSCELL(R)                                         
AUSRIA(R)                                          
AUSZYME(R)                                         
AXSYM(R)                                           
AXSYM2(TM)                                         
AXSYM CORE(TM)                                     
AXSYM CORE-M(TM)                                   
AXSYM EXTEND(R)                                    
C 1600(TM)                                         
C 8000(TM)                                         
CCX (stylized)(TM)                                 
CDIM(R)                                            
CELL-DYN(R)                                        
CELL-DYN DIFFERENTIATOR(TM)                        
CELL-DYN HEMAFLEX(TM)                              
CELL-DYN HEMCAL(R)                                 
CELL-DYN(R)NAVIGATOR                               
CELL-DYN(R)WORKCELL                                
CHEMIFLEX(R)                                       
CHLAMYDIAZYME(R)                                   
CI 8200(TM)                                        
CLEARMEASURE(TM)                                   
CLEARSENSE(TM)                                     
COMMANDER(R)                                       
CONSULTIVITY(TM)                                   
CORAB(R)                                           
CORZYME(R)                                         
CLEARMEASURE(TM)                                   
CLEARSENSE(TM)                                     
DATATRAC(TM)                                       
DATAWAY(TM)                                        
DIABETES NOW(R)                                    
                                                   
DIAGNOSTICSSERVICE.COM(TM)                         
                                                   
DRUG ID(TM)                                        
                                                   
DRUG TRACE(TM)                                     
                                                   
DYNA-LYTE(R)                                       
                                                   
EASYSENSE(TM)                                      
                                                   
EDI(TM)                                            
               
EI (DESIGN)(TM)                                    
                                                   
EPX(R)                                             
ERGODYNAMIC(TM)                                    
EXACTECH(R)                                        
EXPECT MORE. DEMAND MORE.(with Corporate Logo)(TM) 
EXPLORATIONS AND INNOVATIONS(TM)                   
                               
FASTTRACK(TM)                                      
                               
FIREFLY(TM)                                        
                               
FLEX PROTOCOL(TM)                                  
                               
FLEXIBLE PLATFORM(TM)                              
                               
FLEXRATE(TM)                                       
                               
FPC(TM)                                            
                               
GLYCORACK(TM)                                      
                               
GO(TM)                                             
                               
HAVAB(TM)                                          
                               
HAVAB(TM)-M                                        
                               
HEMATOLOGY.COM(TM)                                 
            
HIVAB(TM)                                          
                              
HIVAG with Corporate Logo(TM)                      
                              
HTDX(TM) | I 500(TM)
I 1000(TM)
I 2000(R)                        
                                 
I 2000 SR(R)                     
                                 
I 4000(TM)                       
                                 
I 6000(TM)                       
                                 
I 8000(TM)                       
                                 
IIMPACT(TM)                      
                                 
IMMEDIATE CARE DIAGNOSTICS(R)    
                                 
IMMUNO PLT(TM)                   
IMX (stylized)(R)
IMX CORE(TM)
IMX CORE-M(TM)
IMX SELECT(R)
INVITRODIAGNOSTICS.COM(TM)
LSI(R)                 
                       
LYSOR(R)               
                       
M 1000 (AND DESIGN)(TM)
                       
MAPSS(TM)              
                       
MASTERCHECK(R)         
                       
MEDISENSE(R)           
                       
MEDISENSE and design(TM)              
                               
MEDISENSE FRIENDS FOR LIFE(TM) 
MICROFLO(TM)
MTDX(TM)
MULTIGENT(TM)
MUREX LOGO(R)
NO LINE. THEY MIGHT DO TIME.(TM)
NUMBER WISE(TM)
OBC(R)
OMEC(TM)
OPENCODE(TM)
OPTIMIZED MEC(TM)
PENTAWASH(R)
PMTS(R)
PPC(TM)
PRECISION(TM)
PRECISION A1C(TM)
PRECISIONoG (stylized)(R)
PRECISION LINK(R)
PRECISION OPTIUM(TM)
PRECISION PCX(TM)
PRECISION QoIoD (stylized)(R)
PRECISION SOFTSHIELD(TM)
PRECISION XCEED(TM)
PRO-FILES(TM)
PROQUANTUM(R)
PROTECX(TM)
QC Manager(TM)
QCP(TM)
QUANTUM(TM)
QUANTUMATIC(TM)
QWIKWASH(R)
R.S.G.(R)
RAB(R)
RAPIDDIAGNOSTICS.COM(TM)
REA(R)
REAGENT MAPPING(TM)
RETIC-RITE(R)
RIABEAD(R)               
                         
SCIENCE YOU CAN HUG(TM)  
                         
SENSITACT(TM)            
                         
SERA-SEAL(R)             
                        
SERIES II(TM)            
                        
SIGNIFY(R)
SMARTWASH(TM)
SMS(TM)
SOFTACT(TM)
SOLARIS(TM)
SOLARTEK(TM)
SOLECT(TM)
SOLUTIONS SOURCE(TM)
SONUS PHARMACEUTICALS AND DESIGN(R)
SPA(TM)
STAT-1(TM)
SYNETIICS(TM)
TDX FLX(R)
TDX (stylized)(R)
TETRABEAD(R)
THYMUNE(R)
THYPINONE(R)
THYROGRAPH(R)
TOTAL PROCESS CONTROL(TM)
TOXO G-EIA(TM)
TOXO-G(TM)
TOXO-M(TM)
TPC(TM)
TRIOBEAD(R)
TRUECONTROL(TM)
TRUEMEASURE(R)
TRUESENSE(TM)
TURBO (with design)(R)
ULTRA TLC(R)
URIPROBE(R)
VISIONAID(TM)
WITHEASE(TM)
WORKING SMART(TM)
  
XSYSTEMS(TM)  
              
ZERO PLUS(TM)

---

IMPORTANT: There should be no display
of a trademark in the plural form, no possessives, or removal or addition of hyphens.
Trademarks are to be spelled with initial capitals, all capital letters, or in a
distinctive manner.

---

# EXHIBIT 1.7

# NON-EXCLUSIVE
PHYSICIANS

[***************************************]

---

EXHIBIT 2.4

DIRECT ACCOUNTS

[***************************************]

---

EXHIBIT 3.2

APP PARTICIPATION
CRITERIA

Physicians Office Customers desiring
to participate in the Diagnostics Purchase Plan to receive the use of any Abbott
Owned Equipment shall be required to enter into a written agreement with PSS in a
form approved in writing by Abbott. At minimum, such agreement (the current form of which
is included on this Schedule) shall contain the following terms:

|1. | The
participating Physicians Office Customers shall be required to purchase
               minimum quantities of Abbott reagents from PSS equivalent to $750, $750 or
               $2,500 per month for Quantum, IMx or AxSYM Instruments, respectively
(measured                on the basis of Abbotts prices to PSS hereunder for such
reagents). (See                Diagnostics Purchase Plan, General Terms and Conditions,
Section 1.)
|-- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|2. | The
participating Physicians Office Customers shall be required to comply with
               the Equipment Terms and Conditions Exhibit to the Abbott Diagnostics
Purchase                Plan. Any modifications to such terms shall require Abbotts
prior written                approval.
|-- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|3. | Abbott
shall be specifically identified as the owner of the Abbott Instruments
               and a third party beneficiary of the PSS-Physicians Office Customer
agreement                with the express right for Abbott to enforce the agreement
directly against the                Physicians Office Customer by legal action and/or
repossession of the Abbott                Instruments. (See Diagnostics Purchase Plan,
Equipment Terms and Conditions                Exhibit, Section 4. Title to Equipment.)
PSS shall promptly notify Abbott of any                Physicians Office Customer
breaches of such agreements.
|-- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

---

ABBOTT DIAGNOSTICS
PURCHASE PLANABBOTT DIAGNOSTICS
DIVISION, ABBOTT LABORATORIES INC., D-943 AP6C, 100 ABBOTT PARK ROAD,ABBOTT PARK,
ILLINOIS 60064-6095

|Shipping Address ("Customer"): | Billing Address:
|------------------------------ | ----------------
|Name                           |                 
|Address                        |                 
|City, State, ZIP               |                 
|Number of Doctors / 
Beds      |                 
|Customer Number (s)            |                 
|Type of Practice               |                 
|Purchase Order No.             |                 

GENERAL TERMS AND
CONDITIONS

|1. | Customer
agrees to purchase, each quarter, the products on the Price Exhibit                     (Products),
at the prices and volumes indicated, for the period shown as                     Plan
Term above in the header of this page (collectively referred to
                    hereinafter as the Purchase Commitment). Customer agrees
to meet the                     Purchase Commitment by purchasing Products from Abbott
Diagnostics Division                     (Abbott) or its authorized
distributor, Physician Sales and Service                     (PSS).
|-- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|2. | If
Customer elects to receive Abbott-Owned equipment, Abbott will supply, for
                    the laboratorys use, the equipment listed on the attached Price
Exhibit                     (Equipment). Abbott retains title to the
Equipment provided to                     Customer hereunder. In addition to the terms
and conditions referred to in this                     Plan, the terms and conditions set
forth in the attached Equipment Terms and                     Conditions Exhibit shall
also be applicable and shall be incorporated herein by                     reference.
Should Customer fail to meet ninety percent (90%) of the Purchase
                    Commitment for Products as defined on the Price Exhibit for any two
consecutive                     calendar quarters, Abbott or PSS, as applicable, may at
its election, either (a)                     adjust Customers Product volume price
discount accordingly based upon the                     difference in actual Product
purchased versus Purchase Commitment, or (b)                     terminate this Plan.
|-- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|3. | Prices
set forth on the Price Exhibit are guaranteed for one year. Abbott or
 PSS, as applicable, may increase prices by an amount not to exceed
five percent (5%) or the then current National Consumer Price Index
(CPI), whichever is lower, in any year beyond the initial year of the
Plan.
|-- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|4. | Disclosure.
The purchase prices under this Plan (including the value of any
 discounts, rebates, prepaid allowances, or price concessions) are
intended to reflect discounts or other reductions in price within the
meaning of 42 U.S.C. § 1320a-7b(b)(3)(A) and may reflect a
bundled discount pricing arrangement.  With regard to any bundled
discount pricing arrangement, Abbott shall timely provide Customer
further detail pertaining to the allocation of such discounted
  purchase prices to equipment, service and products. Customer may have
an obligation to report such discounts (as appropriately allocated
among equipment, service and products, if part of a bundled discount
pricing arrangement) to any State or Federal Program that provides
reimbursement to the Customer for the items to which the discount
applies and, if so, Customer must fully and accurately report such
discounts. Further, Customer shall retain invoices and                     other price
documentation and make them available to federal or state officials
                    upon request.
|-- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|5. | Shipping
charges for the Equipment and suppies are prepaid and added to the
                    invoice. Customer is responsible for paying the shipping charges.
Purchase Order                     Number shown in header above shall apply to equipment
shipment charges.
|-- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|6. | Payment
terms are net thirty (30) days. Unless Customer is tax exempt any excise
                    or other taxes applicable to accepted orders as well as shipping
charges will be                     added to the invoice. Past due balances are subject
to a service charge of 1                     1⁄2% per month (or the highest rate
allowed by law, if lower than 1                     1⁄2% per month).
|-- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

---

|7. | Customer
may not assign or transfer this Plan and / or Equipment without  Abbotts
prior written consent.
|-- | ---------------------------------------------------------------------------------------------------------

|8. | Should
Customer terminate this Plan prior to the expiration of the Plan term by giving Abbott
ninety (90) days written notice to the address listed at the top of this document,
Customer is required to pay Abbott a fee which covers the costs associated with
initial Equipment operator training, costs Abbott may have incurred      on the behalf of
Customer at the time of Equipment installation, and costs associated with Equipment
     re-certification (collectively referred to as Equipment Recovery Fees).  Customers
Equipment Recovery Fee is fifty percent (50%) of the then-current published list
price of Equipment.
|-- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|9. | Abbott
warrants and represents that products and/or items of equipment delivered
                    to carrier for shipment to Customer, or delivered directly to
Customer, will at                     the time of such delivery: (a) conform to published
specifications set forth in                     the applicable Abbott package insert(s)
for such product and/or item of                     equipment; (b) not be adulterated or
misbranded within the meaning of the U.S.                     Food, Drug and Cosmetic
Act; and (c) be of good quality and free from defects in                     materials
and workmanship. The only other warranties made by Abbott with respect
                    to products and/or equipment are those specifically and expressly
stated as                     warranties in the Abbott package insert specifications and
manuals. ABBOTT MAKES                     NO OTHER WARRANTIES, EXPRESS OR IMPLIED,
INCLUDING BUT NOT LIMITED TO,                     WARRANTIES AS TO MERCHANTABILITY,
FITNESS FOR A PARTICULAR PURPOSE, OR ANY OTHER                     MATTER.
Notwithstanding the foregoing, any warranties provided by Abbott will
                    not apply to any product and/or item of equipment delivered to
Customer facility                     hereunder, if it has been misused, altered, damaged
or used other than in                     accordance with the applicable Abbott package
insert and/or manual for such                     product and/or item of equipment
(including the substitution of any reagent not                     authorized by Abbott)
or any applicable operator manual so as to affect its                     stability or
reliability; if the serial or lot number of any product and/or item
                    of equipment has been altered, defaced, or removed; or if any repair
is                     attempted by personnel unauthorized by Abbott to perform such
repair.
|-- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | Customer assumes
all risk for the suitability of the test results obtained by using any item of equipment
and/or product hereunder, and the consequences which flow therefrom when such item(s) of
equipment and/or product(s) are used other than in accordance with the applicable Abbott
package insert for such item of equipment or product(s) or any applicable operator manual
so as to effect its stability or reliability, and is used either: (i) alone; or (ii) in
combination with other articles, substances or reagents (or any combination thereof) not
provided or recommended for use with each such equipment and product(s). IN NO EVENT
SHALL ABBOTT BE LIABLE FOR ANY CONSEQUENTIAL, INDIRECT, INCIDENTAL OR SPECIAL DAMAGES OR
LOSSES OF ANY NATURE WHATSOEVER (INCLUDING WITHOUT LIMITATION, LOST REVENUE, LOST
PROFITS, OR LOST BUSINESS, OR LIABILITY OR INJURY TO THIRD PERSONS) ARISING OUT OF THIS
PLAN OR THE USE OF EQUIPMENT OR PRODUCTS OR ABBOTTS NON-WILLFUL FAILURE TO SUPPLY
EQUIPMENT AND PRODUCTS HEREUNDER.
| | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|10. | Customer
acknowledges that Products purchased hereunder are not for resale or
                    distribution to any third party. Customer agrees not to resell
Products on a                     retail basis. At Abbotts request, Customer will
permit Abbott to review                     Customers records to verify compliance
with this own use                    requirement. Further, Customer
represents and warrants that Customer shall use                     Equipment and Product
only for business purposes and not for personal, household                     or family
use. Customer represents and warrants that Customer shall use
                    Equipment and Product only in accordance with the operators
manual and/or                     instructions for use provided by Abbott for use with
such Equipment and Product.
|--- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|11. | Force
Majeure. None of Customer, Abbott or PSS shall not be liable for any
                    failure to perform hereunder (other than the payment of money) due to
strikes                     (legal or illigal), lockouts, fires, floods, or water damage,
riots, government                     acts or orders, interruption of transporation,
inability to obtain material upon                     reasonable prices or terms, or any
other causes beyond its control.
|--- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|12. | By
signing and accepting this Plan, Customer acknowledges that prior to the
                    execution of this Plan, Abbott and PSS offered to sell Products to
Customer,                     and/or sell or lease the Equipment to Customer, seprately,
and that Customer has                     declined those offers, and accepted the terms
of this Plan instead.
|--- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

---

|13. | This
Plan is only complete and in effect, including any addenda or modifications
                    made to this Plan, if accepted and signed by a duly authorized
signatory from                     Abbott. Any modification made to this Plan by the
Customer including, but not                     limited to, handwritten changes whether
on this document or through a Price                     Exhibit, an Addendum or an
Amendment, shall constitute a counteroffer by the                     Customer to Abbott.
Abbott reserves the right to accept, reject or make a                     counteroffer to
Customer with alternative language that is deemed acceptable by
                    Abbott. Abbott will use commercially reasonable efforts to reach an
agreement                     with the Customer on any reasonable modifications requested
in the                     Customers counteroffer. If Customer makes any
modifications to this Plan,                     as stated above, such Plan shall not be
deemed a valid and binding agreement and                     shall automatically become a
working draft to be used by both parties to reach                     terms for a
definitive purchasing agreement.
|--- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

---

AGREED
TO AND ACCEPTED THIS:

---

|CUSTOMER:                                                                           | ABBOTT LABORATORIES INC.:                                                                   
|----------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------
|Signature/Date:________________________   
Print Name/Title: ______________________ | Signature/Effective Date:_______________________
Print Name/Title:__________________________

---

EQUIPMENT TERMS AND
CONDITIONS EXHIBIT

1.     Place of
Equipment

| |  | For the
term of this Plan, Customer shall use the Equipment only at Customers address
specified in this Plan and Customer shall not remove, transfer, or alter the Equipment
without Abbotts prior written consent.
| |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

2.    
          Installation and Servicing of the Equipment

| | 2.1 | Only
Abbott or Abbott-appointed personnel shall service, alter or replace the Equipment and/or
any accessories therefore which are necessary to keep the Equipment in good working
order, excluding items which require replacement with normal use.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | 2.2 | Customer
shall reimburse Abbott or pay for the entire cost of repairing any damage or alteration
to the Equipment caused by Customer, its employees, agents, or contractors or by any
service performed by unauthorized personnel. Abbott shall determine such cost.
| | --- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | 2.3 | Customer
shall use only Abbott reagents, test strips, calibrators, iSTAT® cartridges cartridge
verification kits, and accessories on the Equipment during the term of this Plan.
| | --- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

3.     Service
Considerations of Equipment

| | 3.1 | On-site
service coverage is Monday  Friday, 8:30 a.m.  5:00 p.m. (excluding
holidays). The standard service program includes a maximum number of annual on-site
service calls per Equipment platform: AxSYM®: six (6) service calls; IMx®: three
(3) service calls; TDx® /TDxFLx®: three (3) service calls; ADx®: three (3)
service calls; for ARCHITECT® i2000, ARCHITECT® i4000 and Aeroset®, Abbott
reserves the right to establish a maximum number of annual on-site service calls and
amend this Plan to include this maximum. Service calls beyond the annual limit will be
invoiced at a set charge of six hundred dollars ($600.00) per call. For i-STAT® Equipment,
technical support on service issues can be reached at 1-800-366-8020.
| | --- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | 3.2 | Service
coverage includes all parts (excluding consumables and disposables), travel, and labor.
| | --- | -----------------------------------------------------------------------------------------------

| | 3.3 | If
the Equipment being maintained has preventative maintenance requirements, the procedures
will be performed during the service call.
| | --- | --------------------------------------------------------------------------------------------------------------------------------------

| | 3.4 | Customer
agrees to perform all required operator maintenance as listed in the applicable Abbott
operators manual. If it is determined by Abbott that Customer failed to perform
required maintenance, Abbott reserves the right to charge Customer, and Customer agrees
to pay for any resulting service calls at Abbotts current published time and
material service rates. If Customer requires a service call to provide and/or replace any
consumable parts, they will be charged, and Customer agrees to pay for the call at Abbotts
current published time and material service rate.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

4.     Title to
the Equipment

| | 4.1 | Abbott
is the owner of, and retains title to, the Equipment except to the extent of Equipment
purchases required under Section 5 Risk of Loss or affected under paragraph 4.4 of this
section. These terms and conditions shall terminate automatically with respect to any
such Equipment purchased by Customer.
| | --- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

---

| | 4.2 | Customer
shall not permit or suffer any attachment, encumbrance, lien, or security interest to be
filed against Equipment, shall promptly notify Abbott if any of the foregoing is filed or
claimed, and shall indemnify Abbott for any loss or damage including attorneys fees
resulting from any of the foregoing.
| | --- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | 4.3 | Customer
authorizes Abbott and its agents to execute on Customers behalf and to file UCC
financing statement(s) describing any Equipment provided to Customer under this Plan,
including any replacement or substitutions thereof, and amendment(s) to such financing
statements(s) and ratifies any such financing statement(s) or amendment(s) filed prior to
the date of the Plan.
| | --- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | 4.4 | Customer
may, at any time, purchase the Equipment from Abbott upon terms and conditions of sale
established by Abbott.
| | --- | ----------------------------------------------------------------------------------------------------------------------

5.     Risk of
Loss

| |  | So long
as Abbott retains title to the Equipment pursuant to Paragraph 4.1, above, Abbott shall
be responsible for any loss or damage resulting from the use of the Equipment in
accordance with the package inserts, operator manuals and other technical documents
provided to Customer by Abbott; however, if such loss or damage is due to Customers
negligence of willful misconduct or the performance of service by personnel not
authorized by Abbott, including, but not limited to, improper storage, unauthorized
transfer or removal of Equipment or unsecured or inconsistent power supply, unauthorized
modification or misuse or failure to comply with installation operational and maintenance
requirements and specifications, all as set forth in the package inserts and operators
manual and other technical documents provided to Customer by Abbott, then Customer is
responsible for such loss or damage, and if Abbott determines the damaged Equipment is
irreparable, Customer shall pay Abbott the then-current catalog trade price for such
Equipment less depreciation determined on a ten (10) year straight line basis (prorated
monthly) and, thereupon, Customer will own such Equipment AS IS with all
faults and defects. Additionally, Customer shall be responsible for any loss or damage to
Equipment due to flooding, fire or other natural disasters.
| |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

6.     Labels

| |  | Customer shall
not remove any labels, symbols or serial numbers that are or may be affixed to any items
of Equipment, except as required or approved by Abbott in writing.
| |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------

7.     Taxes

| |  | Unless Customer
is fully exempt from all taxes, Customer shall pay all taxes, federal, state and local,
which may be imposed upon use, possession, ownership, or lease of Equipment. Customer
shall reimburse Abbott for any such taxes paid by Abbott.
| |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

8.     Landlords
Waiver

| |  | Unless Customer
owns the facility (and any other facility to which the Equipment may be transferred with
Abbotts prior written consent), Customer shall, upon Abbotts request, furnish
a waiver signed by Customers landlord by which the landlord waives all rights to
seize, possess or withhold any item of the Equipment by reason of Customers failure
to pay its rent to the landlord.
| |  | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

9.     Redelivery
and Renewal

| |  | Upon at
least ninety (90) days written notice to Abbott prior to the expiration of the initial or
any renewal term of this Plan, Customer shall advise Abbott of Customers intention
to return the Equipment to Abbott at the end of the initial or renewal term of this Plan.
The Customer shall return the Equipment freight and insurance prepaid, to Abbott in good
repair, condition and working order, ordinary wear and tear excepted, in a manner and to
a location designated by Abbott. IF CUSTOMER FAILS TO RETURN THE EQUIPMENT AS PROVIDED
HEREIN, THIS PLAN SHALL RENEW FOR ADDITIONAL TERMS OF TWELVE (12) MONTHS EACH.
| |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

---

10.     Equipment
Shipping Charges

| |  | Customer acknowledges
and agrees that Abbott shall invoice Customer directly for Equipment shipping charges and
Customer shall pay such invoice within 30 days of receipt of such invoice.
| |  | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

11.    
          These Equipment Terms and Conditions are hereby incorporated into and made part
          of this Plan.

| |                                  
| | ---------------------------------
| | ________________
Customer Initial

---

IMMUNOASSAY PRICE EXHIBIT
ABBOTT DIAGNOSTICS
DIVISION, ABBOTT LABORATORIES INC., D-943 AP6C, 100 ABBOTT PARK ROAD,ABBOTT PARK,
ILLINOIS 60064-6095

|Shipping Address ("Customer"): | Billing Address:
|------------------------------ | ----------------
|Name                           |                 
|Address                        |                 
|City, State, ZIP               |                 
|Number of Doctors/Beds         |                 
|Customer Number (s)            |                 
|National Account  Affiliation: |                 
|Customer Point of Contact      |                 

Customer Equipment
commitment

|Type | Quantity | AOE/COE* | PO Number (as required)
|---- | -------- | -------- | -----------------------
|     |          |          |                        
|     |          |          |                        
|     |          |          |                        
|     |          |          |                        
|     |          |          |                        
|     |          |          |                        

*Abbott Owned Equipment
/ Customer Owned Equipment

Customer Product Commitment
Some Products listed herein are currently not available for sale ("Unavailable Products"). The Unavailable Products are listed on the
last page of this Price Exhibit.

|List No. | Product**            | Qtr.Volume | Price per Unit | Quarterly $ | Comment
|-------- | -------------------- | ---------- | -------------- | ----------- | -------
|         |                      |            |                |             |        
|         |                      |            |                |             |        
|         |                      |            |                |             |        
|         | Purchase Committment |            |                |             |        

** As applicable, if
Equipment Usage Fee line item(s) appear above and contain a dollar amount in "Quarterly
$" column, Customer agrees to pay the Equipment Usage Fee as a separate charge each
month.  If the Equipment Usage Fee line item(s) show no dollar amount, Customer has
elected to have the Equipment Usage Fee included in Product price per unit.

Additional New Products
List Products that are not listed above. Products will be applied to Purchase Commitment of the Agreement.

|List No. | Product** | Qtr.Volume | Price per Unit | Quarterly $
|-------- | --------- | ---------- | -------------- | -----------
|         |           |            |                |            
|         |           |            |                |            

Unavailable Products
The following Products are currently unavailable. The volume Commitment and prices will
become applicable upon Product availability. Unavailable Products are not applied to the
Purchase Commitment of the Agreement..

|List No. | Product** | Qtr.Volume | Price per Unit
|-------- | --------- | ---------- | --------------
|         |           |            |               
|         |           |            |               

---

|Equipment Shipping Charges | Sample Segment Kit (AxSYM)
|-------------------------- | --------------------------
|
|Architect i2000            |                           
|Architect i2000 SR         |                           
|AxSYM Plus                 |                           
|AxSYM                      |                           
|ADx                        |                           
|IMx                        |                           
|TDx/FLx                    |                           
|Quantum II                 |                           
|Qwik Wash                  |                           
|Flexible Pippetting Center |                           
|Parallel Processing Center |                           
|Dynamic Incubator          |                           
|Total                      |                           

Usage Charges

|Instrument            | Equipment | Service | Monthly Usage Charge
|--------------------- | --------- | ------- | --------------------
|Architect i2000       | $1,400    | $1,100  | $2,500              
|Architect i2000 SR    | $1,200    | $1,050  | $2,250              
|AxSYM Plus            | $345      | $680    | $1,025              
|AxSYM Classic         | $305      | $680    | $985                
|IMx / ADx / TDx / FLx | $100      | $100    | $200                
|FPC                   | $390      | $100    | $490                
|PPC                   | $350      | $140    | $490                

|                                                                                                                                                                                                                                  |                                                                                                                                                                                                                      
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|AGREED TO AND ACCEPTED THIS:
_________________________________________ 
CUSTOMER: DRAFT - NOT FOR CUSTOMER SIGNATURE

Signature/Date: _____________________________________
Print Name/Title: ___________________________________ | _______________________________________________________
 ABBOTT LABORATORIES INC. DIAGNOSTIC DIVISION
 Signature/Date:_______________________________________
 Print Name/Title: ____________________________________

---

EXHIBIT 3.3(b)

AUDIT PROCEDURES

Pursuant
to Article 3: Upon PSSs receipt of written notice from Abbott of at least five (5)
business days prior notice, PSS shall permit Abbott internal auditors or its third party
designee access to each facility where Product is stored in order to verify that storage
conditions consistent with product requirements and labeling are being met, provided that
any such audit shall not exceed five (5) business days. PSS agrees to maintain an adequate
inventory record system capable of tracing the receipt, storage, resale and ultimate
disposition of Product. PSS agrees to permit said auditors access to various books,
records, files and other materials pertaining to the resale, transfer or exchange of
Products and agrees to make such records, files and other materials available for
inspection during regular business hours by Abbott or its designee. PSS shall permit
Abbott to conduct such audits once per calendar year per distribution site except that
Abbott may conduct such audits once per calendar quarter in so far as they have a
reasonable concern that (a) sales records and/or chargeback requests reported to Abbott by
PSS may contain errors whether intentional or unintentional (b) a PSS facility has sold,
transferred or exchanged Product to customers other than those authorized or, (c) a PSS
facility has stocked or is stocking non-excluded Competitive Product.

Abbott
or its designated auditors shall treat all information gathered or observed during such
audits as confidential as previously defined in this agreement.

---

EXHIBIT 3.4(a)

PURCHASE PRICES

[***************************************]

---

EXHIBIT 3.5(c)

SHIPPING CHARGES AND
DISCOUNTS

Weekly Free Freight Order

- Each week every branch may place a stock order that ships to the branch without freight charges.  There is no minimum value
        for the order.
- All free freight orders ship by a refrigerated truck and take three to five business days to deliver.
- All refrigerated truck deliveries should be counted and inspected.  If there is any damage to the stretch-wrap, document the
        damage when the packages/delivery is signed for.  Call Distributor Service the same day you receive the delivery to document
        the situation.

Shipping Charges

- Orders shipped directly to PSS customers are charged shipping.
- Any order shipping to a PSS branch that is not part of a weekly free freight order will be charged shipping.
- Shipping charges are based on the weight of each order.
- Current Rates are in the attached Tables, these rates are subject to change without notice and not fixed by this Agreement.

[**************************************************************************]

Also please refer to PSS
Branch Leader Manual for Abbott Products

These rates are subject to change
without notice and are not guaranteed with this Agreement.

---

EXHIBIT 3.5(d)

RETURNED GOODS
(DISTRESSED INVENTORY) POLICY

- All credit requests must be called into Distributor Service:  800-872-1387.
- Do not create a Vendor Charge Back (VCB).  Abbott does not accept VCB's.
- Product returns must be authorized by and returned to Distributor Service.  Call Distributor Service to document the
         situation and authorize the credit, replacement or return.  800-872-1387.

Also please refer to
PSS Branch Leader Manual for Abbott Products

---

EXHIBIT 3.6PSS CURRENT
DISTRIBUTION CENTERS

PHYSICIAN SALES & SERVICE,
INC.   4345 Southpoint Boulevard, Jacksonville, Florida 32216 (904)332-3000  Accounting
(904)332-3305/Fax (904)332-3070   IT (904)332-3300/Fax (904)332-3200 CED
(904)332-3369/Fax (904)332-3207  CCD (904)332-3093/Fax (904)332-3162   Marketing
(904)332-3310/Fax (904 332-3205   OPS (904)332-3146/Fax (904)380-4507 A/P
(904)332-3315/Fax (904)332-3217   HR (904)332-3320/Fax (904)332-3213   Volume Purchasing
Dept. (904)260-3282/Fax (904)260-1495     Pharmacy Depot (949)250-3067/Fax (949)250-3088

---

|(904)332-3042 | Gary Corless, President                         | (904)380-4507(F)            
|------------- | ----------------------------------------------- | ----------------------------
|(904)332-3146 | Deborah Johansen, Assistant                     |                             
|(904)332-3329 | Eric Miller, Vice President, Finance            |                             
|(904)332-3270 | Brad Hilton, Senior Vice President, Operations  | Deborah Johansen - Assistant
|(904)332-3061 | Joanie Booker, Vice President, Operations       | Susan Scott, Assistant      
|(904)332-3039 | Eddie Dienes, National Vice President, Sales    | Susan Scott, Assistant      
|(904)332-3189 | Scott Helfrich, Vice President, Strategic Sales | Jessie Ahrens, Assistant    
|(904)332-4145 | Bob Gibson, Vice President, Marketing           | Deborah Hampton, Assistant  
|(904)332-3045 | Bob McCart, Vice President, Corporate Accounts  | Karol Bowers, Assistant     
|(904)332-4157 | Steve Martin, Vice President, Vendor Relations  |                             
|             

|(904)332-3459 (904)332-3040                                                                                                                                      | MID-AMERICA REGION   Jim Evans, VP Operations 
Susan Scott, Assistant                                                                                                      | (904)332-3172(F)                                                                                                                                                      
|---------------------------------------------------------------------------------------------------------------------------------------------------------------- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------
|PSS BIRMINGHAM(15) 
602 Cahaba Valley Circle        
Pelham, AL  35124               
(205)985-8800 FAX (205)985-4300 
Chris Day(G) Mike Hallman(O)              | PSS HEARTLAND(54)
Sales Office 
6818 Grover St. #301B           
Omaha, Nebraska  68106          
(402)398-5441 FAX (402)398-5431 
Cliff Ira(S) Tom McClure(O)             | PSS LITTLE ROCK(22)
Sales Office   
1515 Bowman Road, Suite F       
Little Rock, AR  72211          
(501)228-6981 FAX (501)219-1644 
Brian Daniels(S) Tim Diver(O)  
|PSS CHICAGO (53)       
1450 N. McLean Blvd.           
Elgin, IL  60123               
(847)760-3500 FAX (847)429-9772
Greg Cressman(S) Tim Lyons(O)            | PSS HOUSTON (27)          
15550 Vickery Dr., Suite 200       
Houston, TX  77032                 
(281)765-3100 FAX (281)765-3145    
Clint Bennett(G) Anthony Conner(O)  | PSS MEMPHIS (21)        
5950 Freeport Avenue, Ste 109    
Memphis, TN  38141               
(901)366-3100 FAX (901)366-3295  
Jeremy Ross(S) Tim Diver(O)            
|PSS DALLAS (25)         
1419 Dunn Drive                 
Carrollton, Texas 75006         
(972)245-0908 FAX (972)446-4325 
Lee Majerus(G) Tim Browning(O)       | PSS JACKSON(20) Sales Office 
173 E. Market Ridge                 
Ridgeland, MS  39157                
(601)856-5900 FAX(800)827-2002      
Terry Hartley(S) Tim Diver(O) | PSS MINNEAPOLIS (57)       
141 Cheshire Lane, Ste 700        
Minneapolis, MN  55441            
(763)559-3333 FAX(763)476-1438    
Eric Kindgren(S) Arlene Dickey(O)
|PSS HEARTLAND (47)         
14601 West 112th Street           
Lenexa, KS  66215                 
(913)491-3337 FAX (913)491-3383   
Cliff Ira(G) Tom McClure(O) | PSS LAFAYETTE (73)        
3130 N.E. Evangeline Thruway      
Lafayette, LA  70507              
(337)237-5049 FAX (337)237-5866   
Nick Pecoraro(G) Cyndi Aszklar(O)      | PSS NEW ORLEANS (16)    
5600 Jefferson Highway W4#150    
New Orleans, LA  70123           
(504)733-0223 FAX (504)733-4511  
Nick Pecoraro(G) Josh Horton(O)        
|                                                                                                                                                                

|(904)332-3131
(904)332-3235
(502)810-2875 or (904)332-8056                                                                                                                                       | NORTHERN REGION
Mark Steele,Regional VP
Lee Huffman, VP Operations
Sandy Woody, Assistant                                                                                                                               | (502)810-9145(F)                                                                                                                                                         
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|PSS BALTIMORE/ WASHINGTON   (41)Sales Office          
7520 Connelly Drive, Suite B      
Hanover, MD  21076                
(410)582-9542 FAX (410)582-9560   
Mike Scott(S) Steve Tarantino(O) | PSS LOUISVILLE (56)       
5150 Interchange Way, Suite B    
Louisville, KY  40229            
(502)810-2800 Fax (502)810-9145  
Richard Shadwick(S)              
Robert Ozenbaugh(O)                                  | PSS NORFOLK(39)Sales Office
206 Research Drive, Suite 103      
Chesapeake, VA  23320              
(757)547-0217 FAX (757)547-0216    
Billy Boros(S) Steve Tarantino(O)
|PSS CINCINNATI(43)Sales Office 
11121 Kenwood Road                
Cincinnati, OH  45242             
(513)985-0525 FAX (513)985-0236   
Kelly Guerin(S)Robert Ozenbaugh(O)                      | PSS MID ATLANTIC (59)     
208 Passaic Avenue                
Fairfield, New Jersey  07004      
(973)775-8600  FAX (973)775-8521  
Jeff Plumb(G) 8359                
  Jeff Cavaliere(S) 8259
Patrick Dunigan(S) 8267 | PSS PITTSBURGH (60)              
1030 McKee Road                   
Oakdale, PA  15071                
 (412)494-7610 FAX (412)494-7620  
Mark McKenna(S)  Dave Lamb(O) 
|PSS CLEVELAND (72)     
2003-3 Case Parkway South       
Twinsburg, OH  44087            
(330)425-3832 FAX (330)425-3836 
Tim Buchanan(S) John Hollis(O)                                        | PSS NEW ENGLAND (58)    
Wareham Industrial Park,         
#4 Thacher Lane                  
Wareham, MA  02571               
(508)291-2800 FAX (508)291-2392  
John Brophy(S) Steve Kiewiet(O)                        | PSS RICHMOND (45)          
1950 Ruffin Mill Road             
Colonial Heights, VA 23834        
(804)253-1500 FAX (804)253-9230   
Billy Boros(S) Steve Tarantino(O)   
|                                                                                                                                                                                                

|(904)332-3009
(904) 332-3381
(904) 332-3055                                                                                                                            | SOUTHERN REGION
Tom Fitzgerald, Regional VP
Nick Stark, VP Operations
Priscilla Green, Assistant                                                                                                                 | (904) 332-3349 (F)                                                                                                                                                                  
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|PSS ATLANTA (11)        
4105 Royal Drive, Suite 600     
Kennesaw, Georgia 30144         
(678)813-4000 FAX (678)813-4195 
Lee Smith(G)  Steve Brooks(O)              | PSS COLUMBIA(14)Sales Office 
8901 Farrow Road, Suite 104         
Columbia, South Carolina 29203      
(803)865-0074 FAX (803)699-5227     
Mike Bliss(S)  Matt Reid(O)                                         | PSS KNOXVILLE(23)Sales Office  
3010 Industrial Parkway East       
Knoxville, TN  37921               
(865)546-7771 FAX (865)523-1476    
Keith Dell(G)  Steve Brooks(O)          
|PSS CAROLINAS (31)      
6701 Northpark Blvd, Suite A.    
Charlotte, N.C. 28216            
(704)916-3800 FAX (704)916-3995  
Richard Bigham(S) Matt Reid(O)          | PSS FLORIDA (06)             
9695 Delegates Drive, Suite 503     
Orlando, FL  32837                  
(407)563-5770 FAX (407)563-5799     
Bill Alexander(S) 8206  Bill Goyette(S) 8208
Jeff Lavelle(O) - 8306 | PSS RALEIGH(32)Sales Office 
533 Dynamic Drive                  
Garner, NC  27529                  
(919)773-2006 FAX (919)773-3798  
Jeff Perkinson(S) Matt Reid(O)               
|PSS CHATTANOOGA(18)Sales Office
3720 Amnicola Highway, Suite 131  
Chattanooga, Tennessee 37406      
(423)894-8872 FAX (423)698-4960   
Keith Dell(G) Steve Brooks(O) | PSS JACKSONVILLE (01)      
7018 A.C. Skinner Parkway, #220    
Jacksonville,  Florida  32256      
(904)380-5900  FAX (904)281-0752   
Jeff Lott(S)  Mike Weise(O)                                              | PSS ROANOKE (71)        
1549 Lynn Brae Dr.               
Roanoke, VA  24012               
(540)342-2633  FAX (540)342-2470 
Michael Roberts(S)               
Jerome Frederick(O)
|                                                                                                                                                                      

|(904)332-3128
(904)332-4644
(904)332-4699                                                                                                                                | WESTERN REGION
Jay Monaco, Regional VP
David Marriott, VP Operations
Katina Etheredge, Assistant                                                                 | (407)540-9509 (F)                                                                                                                        
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | ---------------------------------------------------------------------------------------------------------------------------------------------------------------- | -----------------------------------------------------------------------------------------------------------------------------------------
|PSS DENVER (50)          
11175 East 55th Avenue, #106     
Denver, CO  80239                
(303)375-7774 FAX (303)373-1607  
Aaron Rhoades(S) Bill Randolph(O)        | PSS PACIFIC NORTHWEST (69) 
1704 B Street, Suite 120          
Auburn, WA  98001                 
(253)929-1700 FAX (253)929-1795   
Mark Bluem(S) Danny Rich(O) | PSS PORTLAND(38)Sales Office
5227 NE 152nd Place
Portland, OR 97230 
(503)253-6404 FAX (503)253-0730   
Eddie Lamotta(S) Danny Rich(O)   
|PSS HAWAII (81)         
99-1434 Koaha Place              
Aiea, HI  96701                  
(808)488-2666 FAX (808)488-0923  
Debby Simpliciano(G)                      | PSS PHOENIX (33)    
3103 E. Broadway Rd. #100
Phoenix, Arizona 85040
(602)232-4899 FAX(602)232-4876   
Brad Sinclair(S)  Gil Howie(O)                           | PSS SALT LAKE CITY (66)    
3044 South 1030 West
Salt Lake City, UT 84119
(801)977-0848 FAX (801)908-0562   
Greg Dorius(S) Nora Lasky(O)
|PSS NORTHERN CALIFORNIA (49)
20991 Cabot Blvd
Hayward, California  94545
(510)785-1790(P) (510)785-7322 FAX
Jon Ashworth(S) 8228  Scott Hebisen(O)
Randy Stader (S) 7875 |                                                                                                                                                                  |                                                                                                                                          

Note:   Unless specified
above, in order to leave a message for any leader in corporate voicemail, dial 83 +
Branch # for Ops Leaders, and dial 82 + Branch # for Sales Leaders.  Dial 10 + Branch #
to get main office. 10/06/03

---

EXHIBIT 3.9

ABBOTT DIAGNOSTICS PRODUCT COMPLAINT FORM

DATE____/_____/

DISTRIBUTOR INFORMATION:

Company Name
________________________________________Abbott Customer Number
______________________________Representative Name _________________________________Representative
Name _________________________________

ACCOUNT INFORMATION:

Name
________________________________________________Street Address
______________________________________City ________________________State____Zip
Code_______

Phone ___________________

Contact Name
________________________________________

PRODUCT INFORMATION:

Description
____________________________List #__________________Date of Complaint _______/______/Serial
Number __________________________or Lot Number ___________________________Nature of
Complaint __________________________________________________________________________

---

---

Call the appropriate Abbott
Diagnostics Customer Support Center to report product concerns or questions. If the
Support Center is not available, the Distributor Representative must complete all areas of
this form and FAX it to the appropriate Customer Support Center. A customer Support
Specialist will call the account between 7:30am and 6:00pm Central time.

|Customer Support Center | 1-800-#        | FAX           
|----------------------- | -------------- | --------------
|Cell-Dyn                | 1-800-235-5396 | 1-408-982-4866
|IMx/Spectrum            | 1-800-527-1869 | 1-214-518-7476
|Vision/TestPack         | 1-800-323-9100 | 1-708-938-6255

Abbott LaboratoriesDept.
34G, Bldg. AP6CCustomer Support Center

100 Abbott Park Road,
Abbott Park, IL 60064-3500

---

004.370277.1

EXHIBIT 3.12(b)

EXCLUDED COMPETITIVE
PRODUCTS

[**************************************************************************]

---

EXHIBIT 9.11

ALTERNATIVE DISPUTE
RESOLUTION

The parties recognize that bona fide
disputes as to certain matters may arise from time to time during the term of this
Agreement which relate to either partys rights and/or obligations under this
Agreement. To have such a dispute resolved by this Alternative Dispute Resolution
(ADR) provision, a party first must send written notice, as provided in
Section 9.8 of the Agreement, of the dispute to the other party for attempted resolution
by good faith negotiations between their respective presidents (or their designees) of the
affected subsidiaries, divisions, or business units within twenty-eight (28) days after
such notice is received (all references to days in this ADR provision are to
calendar days).

If the matter has not been resolved
within twenty-eight (28) days of the notice of dispute, if the parties fail to meet within
such twenty-eight (28) days, or if the parties have not agreed in writing to extend the
time for good faith negotiations beyond the twenty-eight (28) day period, either party may
initiate an ADR proceeding as provided herein. The parties shall have the right to be
represented by counsel in such a proceeding.

|1. | To
begin an ADR proceeding, a party shall provide written notice to the other
 party of the issues to be resolved by ADR, including the specific
provisions of the Agreement in issue. Within fourteen (14) days after its
receipt of such notice, the other party may, by written notice to the
party initiating the ADR, add additional issues to be resolved within the
same ADR.
|-- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|2. | Within
twenty-one (21) days following receipt of the original ADR notice, the
 parties shall select a mutually acceptable neutral to preside in the
resolution of any disputes in this ADR proceeding. If the parties are
unable to agree on a mutually acceptable neutral within such period,
either party may request the President of the CPR Institute for Dispute
Resolution (CPR), 366 Madison Avenue, 14th Floor, New York,
New York 10017, to select a neutral pursuant to the following procedures:
|-- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | (a) | The
CPR shall submit to the parties a list of not less than five (5) candidates
          within fourteen (14) days after receipt of the request, along with a Curriculum
          Vitae for each candidate. No candidate shall be an employee, director, or
          shareholder of either party or any of their subsidiaries or affiliates.
| | --- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | (b) | Such
list shall include a statement of disclosure by each candidate of any
          circumstances likely to affect his or her impartiality.
| | --- | --------------------------------------------------------------------------------------------------------------------------------------------

| | (c) | Each
party shall number the candidates in order of preference (with the number           one
(1) signifying the greatest preference) and shall deliver the list to the           CPR
within seven (7) days following receipt of the list of candidates. If a           party
believes a conflict of interest exists regarding any of the candidates,           that
party shall provide a written explanation of the conflict to the CPR along           with
its list showing its order of preference for the candidates. Any party           failing
to return a list of preferences on time shall be deemed to have no order           of
preference.
| | --- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | (d) | If
the parties collectively have identified fewer than three (3) candidates           deemed
to have conflicts, the CPR immediately shall designate as the neutral the
          candidate for whom the parties collectively have indicated the greatest
          preference, excluding any candidate deemed by a party to have conflicts. If a
          tie should result between two candidates, the CPR may designate either
          candidate. If the parties collectively have identified three (3) or more
          candidates deemed to have conflicts, the CPR shall review the explanations
          regarding conflicts and, in its sole discretion, may either (i) immediately
          designate as the neutral the candidate for whom the parties collectively have
          indicated the greatest preference, or (ii) issue a new list of not less than
          five (5) candidates, in which case the procedures set forth in subparagraphs
          2(a)  2(d) shall be repeated.
| | --- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|3. | No
earlier than twenty-eight (28) days or later than fifty-six (56) days after
               selection, unless otherwise agreed to in writing by the parties, the
neutral                shall hold a hearing to resolve each of the issues identified by
the parties.                The ADR proceeding shall take place at a location agreed upon
by the parties. If                the parties cannot agree, the neutral shall designate a
location other than the                principal place of business of either party or any
of their subsidiaries or                affiliates.
|-- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|4. | At
least seven (7) days prior to the hearing, each party shall submit the
          following to the other party and the neutral:
|-- | ---------------------------------------------------------------------------------------------------------------------------------

| | (a) | a
copy of all exhibits on which such party intends to rely in any oral or           written
presentation to the neutral;
| | --- | ------------------------------------------------------------------------------------------------------------------------

| | (b) | a
list of any witnesses such party intends to call at the hearing, and a short
          summary of the anticipated testimony of each witness;
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------

| | (c) | a
proposed ruling on each issue to be resolved, together with a request for a
          specific damage award or other remedy for each issue. The proposed rulings and
          remedies shall not contain any recitation of the facts or any legal arguments
          and shall not exceed one (1) page per issue.
| | --- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | (d) | a
brief in support of such partys proposed rulings and remedies, provided
          that the brief shall not exceed twenty (20) pages. This page limitation shall
          apply regardless of the number of issues raised in the ADR proceeding.
| | --- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| |  | Except as
expressly set forth in subparagraphs 4(a)  4(d), no discovery shall be required or
permitted by any means, including depositions, interrogatories, requests for admissions,
or production of documents.
| |  | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|5. | The
hearing shall be conducted on two (2) consecutive days and shall be governed           by
the following rules:
|-- | ------------------------------------------------------------------------------------------------------------------

| | (a) | Each
party shall be entitled to five (5) hours of hearing time to present its           case.
The neutral shall determine whether each party has had the five (5) hours           to
which it is entitled.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | (b) | Each
party shall be entitled, but not required, to make an opening statement,           to
present regular and rebuttal testimony, documents or other evidence, to
          cross-examine witnesses, and to make a closing argument. Cross-examination of
          witnesses shall occur immediately after their direct testimony, and
          cross-examination time shall be charged against the party conducting the
          cross-examination.
| | --- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | (c) | The
party initiating the ADR shall begin the hearing and, if it chooses to make           an
opening statement, shall address not only issues it raised but also any           issues
raised by the responding party. The responding party, if it chooses to           make an
opening statement, also shall address all issues raised in the ADR.           Thereafter,
the presentation of regular and rebuttal testimony and documents,           other
evidence, and closing arguments shall proceed in the same sequence.
| | --- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | (d) | Except
when testifying, witnesses shall be excluded from the hearing until           closing
arguments.
| | --- | -------------------------------------------------------------------------------------------------------

| | (e) | Settlement
negotiations, including any statements made therein, shall not be           admissible
under any circumstances. Affidavits prepared for purposes of the ADR           hearing
also shall not be admissible. As to all other matters, the neutral shall           have
sole discretion regarding the admissibility of any evidence.
| | --- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|6. | Within
seven (7) days following completion of the hearing, each party may submit
               to the other party and the neutral a post-hearing brief in support of its
               proposed rulings and remedies, provided that such brief shall not contain
or                discuss any new evidence and shall not exceed ten (10) pages. This page
               limitation shall apply regardless of the number of issues raised in the
ADR                proceeding.
|-- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|7. | The
neutral shall rule on each disputed issue within fourteen (14) days
               following completion of the hearing. Such ruling shall adopt in its
entirety the                proposed ruling and remedy of one of the parties on each
disputed issue but may                adopt one partys proposed rulings and
remedies on some issues and the                other partys proposed rulings and
remedies on other issues. The neutral                shall not issue any written opinion
or otherwise explain the basis of the                ruling.
|-- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|8. | The
neutral shall be paid a reasonable fee plus expenses. These fees and
               expenses, along with the reasonable legal fees and expenses of the
prevailing                party (including all expert witness fees and expenses), the
fees and expenses of                a court reporter, and any expenses for a hearing
room, shall be paid as follows:
|-- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | (a) | If
the neutral rules in favor of one party on all disputed issues in the ADR,           the
losing party shall pay 100% of such fees and expenses.
| | --- | --------------------------------------------------------------------------------------------------------------------------------------------------

| | (b) | If
the neutral rules in favor of one party on some issues and the other party           on
other issues, the neutral shall issue with the rulings a written           determination
as to how such fees and expenses shall be allocated between the           parties. The
neutral shall allocate fees and expenses in a way that bears a           reasonable
relationship to the outcome of the ADR, with the party prevailing on           more
issues, or on issues of greater value or gravity, recovering a relatively
          larger share of its legal fees and expenses.
| | --- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|9. | The
rulings of the neutral and the allocation of fees and expenses shall be
               binding, non-reviewable, and non-appealable (except in the case of fraud
or bad                faith on the part of the neutral), and may be entered as a final
judgment in any                court having jurisdiction.
|-- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|10. | Except
as provided in paragraph 9 or as required by law, the existence of the
               dispute, any settlement negotiations, the ADR hearing, any submissions
               (including exhibits, testimony, proposed rulings, and briefs), and the
rulings                shall be deemed Confidential Information (except for information
contained in                exhibits or testimony that is already public or later becomes
public through no                fault of the parties or which is lawfully disclosed to a
party through an                independent third party). The neutral shall have the
authority to impose                sanctions for unauthorized disclosure of Confidential
Information.
|--- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------